Daicel Corporation
| Booth No. | 2-106 |
|---|
Demonstration
|
|
Discover the latest clinical evidence on 8PN, a gut-derived metabolite from hops.
Discover the latest research findings on AstroHop™(8-PN), a hop-derived gut metabolite attracting attention in recent clinical studies. Learn about the latest insights on Equol and Urolithin as well. Visitors can also sample products containing 8-PN, including protein beverages, vinegar drinks, and granules.
|
| Product / Service |
ASTROHOP™（Hop extract fermentation product） New Products FLAVOCELL™（S-Equol） Urolithin A（Pomegranate-Derived Metabolite） Konjac Ceramide（Konjac Tuber Extract） Lactobionic acid（Lactose ferment） |
|---|---|
| URL | https://www.daicel.com/lifesciences/healthcare/ |
Presentaion
| Date | 11:30 11:35～ | Location | PH |
|---|---|---|---|
| Title | Latest trends in equol products and formulation example proposals | ||
| Detail | As differentiation through equol dosage alone becomes increasingly difficult, the current trend is to enhance consumer-perceived benefits by combining equol with other functional ingredients. In this presentation, we will explore the latest market trends, product development strategies, and emerging combination approaches. Through commercial examples and market insights, we will discuss how synergistic formulations can create new value and provide meaningful differentiation in the growing equol category. | ||
| Date | 15:00 15:05～ | Location | PJ |
|---|---|---|---|
| Title | ”8PN,” the savior of protein price surge, introduction | ||
| Detail | As protein ingredient costs continue to rise, differentiation through higher dosage alone is becoming increasingly difficult. The future lies not in protein quantity, but in protein quality. Discover the value-creating potential of AstroHop® (8-PN), a hop-derived gut metabolite gaining attention through emerging research. In this presentation, we will share the latest human clinical evidence, showcase commercial product examples, and discuss current market performance and sales trends. | ||
| Date | 15:00 15:05～ | Location | PJ |
|---|---|---|---|
| Title | ”8PN,” the savior of protein price surge, introduction | ||
| Detail | As protein ingredient costs continue to rise, differentiation through higher dosage alone is becoming increasingly difficult. The future lies not in protein quantity, but in protein quality. Discover the value-creating potential of AstroHop® (8-PN), a hop-derived gut metabolite gaining attention through emerging research. In this presentation, we will share the latest human clinical evidence, showcase commercial product examples, and discuss current market performance and sales trends. | ||
| Date | 16:00 16:05～ | Location | PH |
|---|---|---|---|
| Title | Latest trends in equol products and formulation example proposals | ||
| Detail | As differentiation through equol dosage alone becomes increasingly difficult, the current trend is to enhance consumer-perceived benefits by combining equol with other functional ingredients. In this presentation, we will explore the latest market trends, product development strategies, and emerging combination approaches. Through commercial examples and market insights, we will discuss how synergistic formulations can create new value and provide meaningful differentiation in the growing equol category. | ||